Humana CMO reports no common stock holdings

Q: How many HUM shares does Shantanu Nundy directly own according to this Form 3?

According to the report, Shantanu Nundy directly owns 0 shares of Humana Common following the reported position.

Q: Does the HUM Form 3 show any recent purchases or sales by Shantanu Nundy?

No. The report contains a single holding entry for Humana Common and shows 0 shares beneficially owned, with no buy or sell transactions indicated.

Q: What type of security is listed for Shantanu Nundy in the HUM Form 3?

The report lists one security type: Humana Common, with a reported beneficial ownership of 0 shares following the position.

HUMANA INC (HUM) reported the initial equity holdings of executive Shantanu Nundy, who serves as Chief Medical Officer.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

HUMANA INC (HUM) reported the initial equity holdings of executive Shantanu Nundy, who serves as Chief Medical Officer. The report lists one line item for Humana Common with 0 shares beneficially owned following the reported position, indicating no direct holdings of Humana common stock at that time.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Nundy Shantanu

Role Chief Medical Officer

Type	Security	Shares	Price	Value
holding	Humana Common	--	--	--

Holdings After Transaction: Humana Common — 0 shares (Direct)

Key Figures

Shares beneficially owned following report: 0 Humana Common shares Holding entries reported: 1 holding entry

2 metrics

Shares beneficially owned following report 0 Humana Common shares Reported for Shantanu Nundy as Chief Medical Officer

Holding entries reported 1 holding entry Number of reported entries for Humana Common

Key Terms

Humana Common, Chief Medical Officer, beneficially owned

3 terms

Humana Common financial

"security_title: "Humana Common""

Chief Medical Officer other

"officer_title": "Chief Medical Officer""

A chief medical officer is a senior executive responsible for overseeing the health and medical strategies within an organization, often in the healthcare or pharmaceutical sectors. They play a key role in guiding decisions related to medical research, product safety, and healthcare policies, which can impact a company's reputation and success. For investors, understanding the chief medical officer's role helps gauge how well a company manages medical risks and advances its healthcare goals.

beneficially owned financial

"total_shares_following_transaction": "0.0000""

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the HUM Form 3 report for Chief Medical Officer Shantanu Nundy?

It reports Shantanu Nundy’s initial beneficial ownership in Humana Common as 0 shares following the reported position, indicating no direct common stock holdings at that time.

How many HUM shares does Shantanu Nundy directly own according to this Form 3?

According to the report, Shantanu Nundy directly owns 0 shares of Humana Common following the reported position.

What is Shantanu Nundy’s role at HUMANA INC (HUM)?

Shantanu Nundy is reported as an officer of HUMANA INC with the title Chief Medical Officer.

Does the HUM Form 3 show any recent purchases or sales by Shantanu Nundy?

No. The report contains a single holding entry for Humana Common and shows 0 shares beneficially owned, with no buy or sell transactions indicated.

What type of security is listed for Shantanu Nundy in the HUM Form 3?

The report lists one security type: Humana Common, with a reported beneficial ownership of 0 shares following the position.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 08/31/2026 - 09:47 AM EDT Accepted by SEC EDGAR 08/31/2026 - 09:47 AM EDT

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Nundy Shantanu

(Last)

(First)

(Middle)

HUMANA INC.

101 E. MAIN STREET

(Street)

LOUISVILLE

KENTUCKY

40202

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
08/31/2026

3. Issuer Name and Ticker or Trading Symbol
HUMANA INC [ HUM ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Medical Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Humana Common	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

	Shantanu Nundy	08/31/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR